Showing results (11-20 of 244) with videos related to
Sort By:
Pageof 25
Critical Reviews in Oncology/Hematology|July 6, 2013
Role of thalidomide in the treatment of patients with multiple myelomaGareth J Morgan, Faith E DaviesBest Practice & Research. Clinical Haematology|March 7, 2020
Monitoring minimal residual disease in the bone marrow using next generation sequencingEven H Rustad, Eileen M BoyleCancer Management and Research|March 11, 2017
Update on the optimal use of bortezomib in the treatment of multiple myelomaMeera Mohan, Aasiya Matin, Faith E DaviesCurrent Opinion in Investigational Drugs (London, England : 2000)|July 12, 2007
Proteasome inhibition and multiple myelomaPamela Kanagasabaphy, Gareth J Morgan, Faith E DaviesEuropean Journal of Haematology|October 27, 2020
Monitoring treatment response and disease progression in myeloma with circulating cell-free DNAShayu Deshpande, Ruslana G Tytarenko, Yan Wang, et al.Expert Opinion on Investigational Drugs|December 22, 2007
An update on drug combinations for treatment of myelomaMuralikrishnan Srikanth, Faith E Davies, Gareth J MorganBritish Journal of Haematology|November 17, 2009
The potential role of epigenetic therapy in multiple myelomaEmma M Smith, Kevin Boyd, Faith E DaviesNature Reviews. Cancer|April 13, 2012
The genetic architecture of multiple myelomaGareth J Morgan, Brian A Walker, Faith E DaviesTherapeutics and Clinical Risk Management|March 25, 2008
Bortezomib (Velcadetrade mark) in the Treatment of Multiple MyelomaAntonia Field-Smith, Gareth J Morgan, Faith E DaviesThe Lancet. Oncology|May 7, 2003
Aetiology of bone disease and the role of bisphosphonates in multiple myelomaAndrew J Ashcroft, Faith E Davies, Gareth J MorganPageof 25